Teva (TEVA) subsidiary agreed to be the stalking-horse bidder for BioXcel Therapeutics' (BTAI) assets in a Chapter 11 auction, offering up to $125M cash plus assumed liabilities.
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Limited, will serve as the initial bidder for substantially all assets of BioXcel Therapeutics, Inc. and certain affiliates through a court-supervised Chapter 11 auction. The proposed consideration includes $57.5 million in cash at closing and up to $67.5 million in contingent cash consideration, totaling a maximum of $125 million, along with specified assumed liabilities. The portfolio includes IGALMI, the associated BXCL501 program, and other assets. The transaction is subject to bankruptcy-court approval and potential superior offers from competing bidders.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Oracle, Meta, and SpaceX credit default swaps (CDS) hit all-time highs, as the market anticipates a surge in AI-related bond issuance in Q4.
-
2
Liu Jun, President of Industrial and Commercial Bank of China (ICBC): Commercial Banks Bear Heavier Financial and Legal Responsibilities Than Central Banks in AI Deployment
-
3
Bain Survey: Chinese Consumers Prioritize Technology in Car Purchases, While Europeans and Americans Still Value Price; Western Automakers Face Dual Pressure
-
4
Anthropic pitches AI safety bill that would require judge's permission to block models
-
5
Anthropic reportedly faces a compute shortage as cloud giants view it as a competitor, plans November IPO.
-
6
Media reports: Amazon Web Services (AWS) has billions of dollars worth of NVIDIA chips backlogged in its warehouses due to power shortages, leading to negative free cash flow.
-
7
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
-
8
NextDC's data center project in Australia faces power supply delays due to resident protests, leading to a more than one-third reduction in its FY2027 earnings guidance and a 45% plunge in its stock price.
-
9
U.S. equity index futures rose, boosted by strong earnings reports from AI-related companies.
-
10
King Charles III of the UK praised Oman's peaceful efforts in reopening the Strait of Hormuz.
Markets Today
Recommended Reading


